AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

Trial Identifier: D7405C00001
Sponsor: AstraZeneca
Start Date: December 2023
Primary Completion Date: July 2026
Study Completion Date: May 2027

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
AU Melbourne, AU, 3000
CA, ON Toronto, ON, CA, M5G 2M9
CN Changsha, CN, 410008
CN Chengdu, CN, 610041
CN Guangzhou, CN, 510060
CN Hangzhou, CN, 310003
CN Nanjing, CN, 210008
CN Nanjing, CN, 210009
CN Suzhou, CN, 215006
CN Zhengzhou, CN, 450008
DE Essen, DE, 45147
DE Frankfurt, DE, 60590
DE Freiburg, DE, 79106
DE Halle, DE, 06120
DE Hamburg, DE, 20246
DE Köln, DE, 50924
DE München, DE, D-81337
DE Münster, DE, 48149
DE Wuerzburg, DE, 97080
ES Barcelona, ES, 08035
ES Madrid, ES, 28025
ES Madrid, ES, 28046
ES Valencia, ES, 46026
FR Caen, FR, 14033
FR Marseille, FR, 13009
FR Nantes, FR, 44000
FR Paris, FR, 75019
FR Pierre Bénite, FR, 69495
FR Toulouse, FR, 31059
GB London, GB, EC1A 7BE
GB Manchester, GB, M20 4BX
GB Surrey, GB, SM1 2DL
IT Bergamo, IT, 24127
IT Bologna, IT, 40138
IT Monza, IT, 20900
IT Napoli, IT, 80122
IT ROMA, IT, 00165
JP Bunkyo-ku, JP, 113-8677
JP Chuo-ku, JP, 104-0045
JP Kashiwa, JP, 277-8577
JP Kyoto-shi, JP, 606-8507
JP Osaka-shi, JP, 545-8586
KR Seoul, KR, 06351
KR Seoul, KR, 03722
KR Seoul, KR, 6591
KR Seoul, KR, 03080
TW Kaohsiung City, TW, 833401
TW Taichung, TW, 40705
TW Tainan City, TW, 70403
TW Taipei, TW, 10002
US, CA Duarte, CA, US, 91010
US, CA Los Angeles, CA, US, 90048
US, CA Palo Alto, CA, US, 94304
US, FL Tampa, FL, US, 33612
US, GA Atlanta, GA, US, 30322
US, IL Chicago, IL, US, 60637
US, NY New York, NY, US, 10016
US, TX Houston, TX, US, 77030
US, VA Richmond, VA, US, 23219
US, WI Milwaukee, WI, US, 53226